Veracyte
VCYT
55 hedge funds and large institutions have $118M invested in Veracyte in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 23 increasing their positions, 11 reducing their positions, and 7 closing their positions.
109% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 11
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
53% more capital invested
Capital invested by funds: $77.5M → $118M (+$40.9M)
5% less funds holding
Funds holding: 58 → 55 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $529K
Top Buyers
| 1 |
CC
Cannell Capital
Alta,
Wyoming
|
+$2.15M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$1.27M |
| 3 |
Renaissance Technologies
New York
|
+$594K |
| 4 |
BC
Birchview Capital
Burlington,
Vermont
|
+$195K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$184K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
BNP Paribas Financial Markets
Paris,
France
| $7.28K | +$2.25K | +398 | +71% |
|
52
BlackRock
New York
| $7K | +$3.53K | +624 | +215% |
|
53
Bank of America
Charlotte,
North Carolina
| $5K | +$1.8K | +318 | +120% |
|
54
Barclays
London,
United Kingdom
| $1K | +$673 | +119 | New |
|
|
TCIM
55
TIAA CREF Investment Management
New York
| $349 | – | – | – |
|
|
CCP
56
Clough Capital Partners
Boston,
Massachusetts
| – | -$1.35M | -267,547 | Closed |
|
|
SCM
57
Stonepine Capital Management
Bend,
Oregon
| – | -$940K | -186,926 | Closed |
|
|
KIA
58
Kopp Investment Advisors
Bloomington,
Minnesota
| – | -$111K | -21,975 | Closed |
|
59
ClearBridge Investments
New York
| – | -$107K | -21,211 | Closed |
|
|
ST
60
Spot Trading
Chicago,
Illinois
| – | -$80K | -15,900 | Closed |
|
61
Goldman Sachs
New York
| – | -$55K | -10,970 | Closed |
|
|
TRCT
62
Tower Research Capital (TRC)
New York
| – | -$2K | -372 | Closed |
|
VCYT Hedge Fund Activity: Q3 2016 in Review
55 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q3 2016, worth a combined $118M — up 53% from $77.5M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of VCYT and 4 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 23 added.
The largest buyer was Cannell Capital, opening a new position worth an estimated $2.15M. The largest seller was Clough Capital Partners, exiting entirely with an estimated $1.35M sold.
- 55 institutional investors held Veracyte (VCYT) as of Q3 2016, down from 58 in Q2 2016.
- Funds reported $118M of Veracyte stock for Q3 2016, up 53% quarter-over-quarter.
- 4 funds opened new Veracyte positions in Q3 2016 and 7 closed out, a net change of -3 holders.
- The largest Veracyte buyer in Q3 2016 was Cannell Capital, an estimated $2.15M added.
- The largest Veracyte seller in Q3 2016 was Clough Capital Partners, an estimated $1.35M sold.
Based on aggregated 13F filings for Q3 2016.